mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced  
Phone 01494 818 000
Current Jobs

Sales Specialist
Location: North East

Product Manager
Location: West Yorkshire

Territory Manager - Sports Medicine
Location: M62 Corridor

Regional Business Manager
Location: North East Region

Sales Specialist - PAS
Location: North East

Expert Trainer
Location: Mid UK

Field Sales Coach - Central
Location: Central UK

Senior Brand Manager
Location: Welwyn Garden City

Territory Manager - Sports Medicine
Location: South Central

Sales Specialist - MSS
Location: West Midlands

Centralised Diagnostics Sales Specialist
Location: South and Central London

Medical Advisor
Location: Princes Risborough, Bucks

Training Manager - Renal & Neurology and ELearnin
Location: Maidenhead, Berks

Training Manager - Part-time
Location: Maidenhead

Territory Manager - Sports Medicine
Location: West Scotland

Genetic link to common form of leukaemia discovered

Posted on 01/09/2008 in Industry related health news

A genetic susceptibility to the most common form of leukaemia has been discovered.

Chronic lymphocytic leukaemia (CLL) is a slowly-progressing form of the disease, and is found in around 2,750 people in the UK every year.

Anecdotal evidence has suggested that inherited factors could have a role in the development of CLL, no genetic basis had been discovered.

But new research - principally funded by Leukaemia Research with additional funding from Cancer Research UK and carried out at The Institute of Cancer Research - could lead to improved treatment for CLL patients after scientists discovered variation in certain genes can explain part of the inherited susceptibility to develop the disease.

Professor Richard Houlston and his team at The Institute of Cancer Research compared DNA from CLL patients with DNA from a healthy group and found six genes with variations in their genetic sequences that are strongly associated with the development of CLL.

"Each of these variations, by itself, has a very small effect on the risk of developing CLL, but when all of them are present there is a significantly increased risk of leukaemia," Professor Houlston said.
"Now that we have this evidence we can carry out studies to determine exactly how the different genes contribute to this risk. "

Professor John Gribben, a Cancer Research UK clinical expert at Barts and The London School of Medicine, said the study's findings were "intriguing".

Other news stories from 01/09/2008

Read more in the Zenopa News Archive

How this news is generated

Angela Robertson
QC/Training Consultant


Pharmaceutical Sales Jobs | Pharmaceutical Executive Jobs | Pharmaceutical Marketing Jobs | Medical Sales Jobs | Medical Devices Marketing Jobs | Medical Executive Jobs
Dental Sales Jobs | Veterinary Sales Jobs | Scientific Sales Jobs | Consumer Healthcare Sales Jobs | Consumer Healthcare Management Jobs | Medical Writing Jobs
Medical Writer Jobs | Healthcare PR Jobs | Animal Health Sales Jobs

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2012 Zenopa Ltd | terms & conditions of use